Showing 161-170 of 3196 results for "".
Clinical Conversations: The Data for JAK Inhibitors in AD
https://practicaldermatology.com/series/jak-inhibitors-in-practice/clinical-conversations-the-data-for-jak-inhibitors-in-ad/20105/JAK inhibitors represent a new therapeutic class for the treatment of atopic dermatitis. Find out what the data show about their efficacy and tolerability in a conversation between Brad Glick, DO and Raj Chovatiya, MD. Discover how these drugs can fit into the treatment plan and how these experts diGold Mettle: Dr. Michael Gold Talks Multifaceted Practice with Dr. Joel Cohen
https://practicaldermatology.com/topics/practice-management/gold-mettle-dr-michael-gold-talks-multifacted-practice-with-dr-joel-cohen/18868/Dr. Michael Gold's thriving Nashville practice includes a busy medical practice, a medical spa, and a research center. Plus, he's involved in teaching and educational ventures globally. How does he do it all—and stay on schedule? Dr. Joel L. Cohen finds out.Neuromodulators and Dermal Fillers: Dr. Gold
https://practicaldermatology.com/programs/practical-dermatology/neuromodulators-and-dermal-fillers-dr-gold/32694/Michael Gold, MD, talks about the new neurotoxins and applications, as well as fillers, that he covered during "Neuromodulators and Dermal Fillers: What's New, What's Coming and What Are We Doing That's New in 2025" at Maui Derm 2025.Enhancing Your Procedures with Chemical Peels & Nutraceuticals
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/enhancing-your-procedures-with-chemical-peels-nutraceuticals/20274/Do chemical peels and nutraceuticals have a place in today's aesthetic practice? Yes, say Vivian Bucay, MD and Erin Gilbert, MD, PhD, speaking at Cosmetic Surgery Forum 2016 in Las Vegas. Get their pearls for successful integration. Get more info on Cosmetic Surgery Forum.Derm Insider: Ethics and Industry: How to Manage Relationships with Pharma
https://practicaldermatology.com/topics/practice-management/derm-insider-ethics-and-industry-how-to-manage-relationships-with-pharma/19029/In this edition, host Neal Bhatia, MD and guests Tom Prunty and James Q. Del Rosso, DO tackle the ethics of industry relationships. They discuss the nuances and challenges of physicians fostering appropriate relationships with pharmaceutical manufacturers amid an increasingly stringent regulatory laThe War Zone: Private Practice
https://practicaldermatology.com/series/the-practical-dermatology-podcast/the-war-zone-private-practice/54847/The War Zone: Private PracticePractical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, and Editorial Board member Collin Blattner, DO, FAAD, discuss strategies for building a successful private practice in the era of private equity, as well as the challenges associated with it.Identifying SCC Risk
https://practicaldermatology.com/topics/skin-cancer-photoprotection/identifying-scc-risk/20144/Sherrif Ibrahim, MD discusses the challenges of managing squamous cell carcinoma (SCC). Great steps have been made in clinical, pathological staging systems, but Dr. Ibrahim says it’s still difficult to determine what to do with borderline cases. He talks about the need to determine frequency and inScience of Skincare Summit 2024: On the FDA Approval of Emrosi for Rosacea
https://practicaldermatology.com/conferences/science-skincare-summit-2024/science-of-skincare-summit-2024-on-the-fda-approval-of-emrosi-for-rosacea/29276/At the Science of Skincare Summit in Austin, Practical Dermatology caught up with Chief Medical Editor Neal Bhatia, MD, and James Del Rosso, DO, a dermatologist and Editor in Chief of Clinical Dermatology at the Journal of Clinical and Aesthetic Dermatology (JCAD), who shared insights and thoughts oUncommon Knowledge: Horses v. Zebras in Pediatric Dermatology
https://practicaldermatology.com/conferences/aad-2021/uncommon-knowledge-horses-v-zebras-in-pediatric-dermatology/19924/Even though uncommon presentations of common conditions are more likely than common presentations of uncommon conditions, uncommon conditions do present, says Colleen Cotton, MD. She addresses the importance of finding the proper diagnosis in pediatric skin disease, noting cases of venous malformatiScientifically Speaking: Correcting and Avoiding Complications in Dark Skin Tones, Part 2 of 2
https://practicaldermatology.com/topics/skin-cancer-photoprotection/scientifically-speaking-correcting-and-avoiding-complications-in-dark-skin-tones-part-2-of-2/19898/Advancements in energy-based devices mean that these tools can be used across a range of skin tones. But complications can and do still occur. In part two of a discussion on EBDs used in darker skin types, host Joel L. Cohen, MD reviews cases with Michelle Henry, MD, Omar Ibrahimi, MD, PhD, and Jenn